PYC Therapeutics (ASX:PYC) raised AU$9.3 million via the retail component of its entitlement offer, bringing the total funds raised to AU$100 million, according to a Tuesday filing with the Australian bourse.
On Feb. 17, the company said it is set to raise up to AU$146 million via a pro-rata accelerated non-renounceable entitlement offer on the basis of one new share for every four shares held.
The balance will be raised through an underwriting facility expected before April 7, the filing said.
Shares of the company fell almost 3% in recent Tuesday trade.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。